WASHINGTON, D.C. 20549

                        Report of Foreign Private Issuer

                        Pursuant to Rule 13a-16 or 15d-16
                        of the Securities Exchange Act of

                                January 20, 2006

                        Commission File Number 001-14978

                               SMITH & NEPHEW plc
                               (Registrant's name)

                                 15 Adam Street
                            London, England WC2N 6LA
              (Address of registrant's principal executive offices)

     [Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]

               Form 20-F  X                   Form 40-F
                         ---                            ---

     [Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]

               Yes                            No  X
                   ---                           ---

     [Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]

               Yes                            No  X
                   ---                           ---

     [Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of

               Yes                            No  X
                   ---                           ---

     If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.



     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                                 Smith & Nephew plc

Date: January 20, 2006
                                                  By:   /s/ Paul Chambers
                                                 Paul Chambers
                                                 Company Secretary


20 January 2006

Smith & Nephew plc (NYSE:SNN;  LSE:SN) will announce its preliminary results for
2005 at 11am GMT/6.00am EST on 9 February 2006. A presentation for analysts will
be held at 1.00pm GMT/8.00am EST which can be seen live via webcast on the Smith
& Nephew  website at  and  available  on the site  archive
shortly afterwards.

The company will announce its quarterly results through the year as follows:

Quarter 1                                             27 April 2006
Interims/Quarter 2                                    27 July 2006
Quarter 3                                             2 November 2006

The company  will host a meeting for  analysts  and  investors  at the  American
Academy of Orthopaedic  Surgeons (AAOS), the largest orthopaedic congress in the
world, at 8.00am (EST) on Wednesday 22 March 2006 in Chicago.

The meeting will be hosted by Sir Christopher O'Donnell,  Chief Executive,  with
presentations from Dave Illingworth,  President of Smith & Nephew's orthopaedics
business, and Jim Taylor, President of the endoscopy business. The presentations
will focus on Smith & Nephew  products being  exhibited by the  orthopaedic  and
endoscopy  businesses at the surgeon meeting.  These will also be broadcast live
by  webcast  on the Smith & Nephew  website  and will be  available  on the site
archive shortly afterwards.
About Us

Smith & Nephew (LSE: SN, NYSE:SNN) is one of the world's leading medical devices
companies,   specialising   in   Orthopaedics,   Endoscopy  and  Advanced  Wound
Management.  Smith & Nephew  ranks  as the  global  leader  in  arthroscopy  and
advanced wound  management  and is the fastest  growing  full-line  orthopaedics
company in the world.

Smith & Nephew is  dedicated  to helping  improve  people's  lives.  The company
prides  itself  on the  strength  of its  relationships  with  its  surgeon  and
healthcare  professional  customers,  with whom its name is synonymous  with the
highest  standards of  performance,  innovation and trust.  The company has over
8,500 employees and operates in 33 countries around the world,  generating sales
of over GBP1.25 billion.


Smith & Nephew UK
Julie Allen                                             Tel: +44 (0)20 7401 7646
Investor Relations Coordinator

Financial Dynamics UK
David Yates/Ben Atwell                                  Tel: +44 (0)20 7831 3113

Financial Dynamics US
Jonathan Birt                                           Tel: +1 212 850 5634